The FDA cleared analytical reactivity information to be added to a package insert for the firm's RAMP Influenza A/B Assay.
The newest authorization allows testing on 3M's molecular diagnostic system.
Nanosphere received FDA clearance for its influenza and respiratory virus test to run on its new Verigene SP System.
A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.